Article
Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 5 Oct 2021
Martinot Martin, Jary Aude, Fafi-Kremer Samira, Leducq Valentin, Delagreverie Heloise, Garnier Marc, Pacanowski Jérôme, Mékinian Arsène, Pirenne France, Tiberghien Pierre, Calvez Vincent, Humbrecht Catherine, Marcelin Anne-Geneviève, Lacombe Karine
Abstract excerpt
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly discovered virus for which remdesivir is the only antiviral available. We report the occurrence of a mutation in RdRP (D484Y) following treatment with remdesivir in a 76-year-old female with post-rituximab B-cell immunodeficiency and persistent SARS-CoV-2 viremia. A cure was achieved after supplementation with convalescent plasma.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
